GDNF and BDNF are two important factors for development, maintenance, and aging of ventral mesencephalic dopamine neurons. It is, however, not possible to study aging effects of complete null mutations of either GDNF or BDNF, since null mutated animals die shortly after birth. In project 0005 we propose to use organotypic tissue culture and grafting techniques to study the development, maintenance, and aging of ventral mesencephalic dopamine neurons in tissue derived from GDNF or BDNF knockout and heterozygous animals. Thus, organotypic tissue cultures of fetal ventral mesencephalon from GDNF-/- and BDNF-/- as well as their heterozygous counterparts will be utilized to study growth factor effects on dopamine nerve fiber formation in comparison with wildtype and heterozygous tissue cultures (Aim 1). To examine aging effects of GDNF or BDNF complete or partial knockout on midbrain dopamine neurons in isolation, fetal ventral mesencephalon and lateral ganglionic eminence will be implanted simultaneously into the lateral ventricle of wildtype mice, so that a nigrostriatal microcircuit will be created of null mutated tissue. Recipients of transplants will then be sacrificed at 3, 12, 18, and 24 months post-grafting, to determine if there are time-dependent detrimental alterations occurring in transplanted tissues during aging as a result of the GDNF or BDNF null mutation. CSF samples will be obtained from the host animals to determine potential influence of the environment on grafted tissues. GDNF and BDNF will be added to the incubation bath prior to grafting in one group of all transplant types to determine if supplementation with the appropriate trophic factors may reverse potential effects of GDNF or BDNF deletion (Aim 2). Combined effects of GDNF or BDNF depletion and early neuroinflammation by prenatal exposure to lipopolysaccharide (LPS) will be studied using organotypic tissue culture (for development studies) and grafting (for aging studies). Finally, exposure to an environmental toxin (methamphetamine) in GDNF or BDNF null mutated nigrostriatal cografts will be studied (Aim 3). The overall goal with Project 0005 is to examine the fate of midbrain dopamine neurons developed and aged in the absence of GDNF or BDNF combined with effects of neuroinflammation and environmental toxins. Furthermore, Project 0005 provides two levels of control studies for the other projects: A) null mutated animals may be studied in grafts or tissue culture to determine the effects of a complete depletion of BDNF or GDNF, and B) we will be able to determine if the effects observed in Project 0001-0004 in vivo are due to intrinsic, brain specific, alterations or to systemic effects, since we will isolate the brain regions in question in intracranial transplants and tissue cultures.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG023630-02
Application #
7309902
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2006-07-01
Budget End
2007-06-30
Support Year
2
Fiscal Year
2006
Total Cost
$131,574
Indirect Cost
Name
Medical University of South Carolina
Department
Type
DUNS #
183710748
City
Charleston
State
SC
Country
United States
Zip Code
29425
Karakostas, Tasos; Hsiang, Simon; Boger, Heather et al. (2014) Three-dimensional rodent motion analysis and neurodegenerative disorders. J Neurosci Methods 231:31-7
Huang, Peng; Ou, Ai-hua; Piantadosi, Steven et al. (2014) Formulating appropriate statistical hypotheses for treatment comparison in clinical trial design and analysis. Contemp Clin Trials 39:294-302
Reinert, Kaela R S; Umphlet, Claudia D; Quattlebaum, Ariana et al. (2014) Short-term effects of an endotoxin on substantia nigra dopamine neurons. Brain Res 1557:164-70
Karakostas, Tasos; Granholm, Ann-Charlotte (2014) Motion capture and associated novel measurement devices for movement function in humans and animal models. J Neurosci Methods 231:1-2
Littrell, Ofelia M; Granholm, Ann-Charlotte; Gerhardt, Greg A et al. (2013) Glial cell-line derived neurotrophic factor (GDNF) replacement attenuates motor impairments and nigrostriatal dopamine deficits in 12-month-old mice with a partial deletion of GDNF. Pharmacol Biochem Behav 104:10-9
Littrell, Ofelia M; Pomerleau, Francois; Huettl, Peter et al. (2012) Enhanced dopamine transporter activity in middle-aged Gdnf heterozygous mice. Neurobiol Aging 33:427.e1-14
Zhang, YaJun; Granholm, Ann-Charlotte; Huh, Kyounghee et al. (2012) PTEN deletion enhances survival, neurite outgrowth and function of dopamine neuron grafts to MitoPark mice. Brain 135:2736-49
Granholm, Ann-Charlotte; Zaman, Vandana; Godbee, Jennifer et al. (2011) Prenatal LPS increases inflammation in the substantia nigra of Gdnf heterozygous mice. Brain Pathol 21:330-48
Boger, H A; Mannangatti, P; Samuvel, D J et al. (2011) Effects of brain-derived neurotrophic factor on dopaminergic function and motor behavior during aging. Genes Brain Behav 10:186-98
Nevalainen, N; Chermenina, M; Rehnmark, A et al. (2010) Glial cell line-derived neurotrophic factor is crucial for long-term maintenance of the nigrostriatal system. Neuroscience 171:1357-66

Showing the most recent 10 out of 30 publications